Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Covington
Novartis
Moodys
Argus Health
Boehringer Ingelheim
Cipla
Teva
Farmers Insurance
Daiichi Sankyo

Generated: October 23, 2017

DrugPatentWatch Database Preview

DIPROLENE Drug Profile

« Back to Dashboard

Which patents cover Diprolene, and when can generic versions of Diprolene launch?

Diprolene is a drug marketed by Schering and Merck Sharp Dohme and is included in four NDAs.

The generic ingredient in DIPROLENE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.

Summary for Tradename: DIPROLENE

US Patents:0
Applicants:2
NDAs:4
Suppliers / Packagers: see list2
Bulk Api Vendors: see list29
Clinical Trials: see list1
Patent Applications: see list2,051
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DIPROLENE at DailyMed

Pharmacology for Tradename: DIPROLENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering
DIPROLENE
betamethasone dipropionate
CREAM, AUGMENTED;TOPICAL019408-001Jan 31, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck Sharp Dohme
DIPROLENE
betamethasone dipropionate
OINTMENT, AUGMENTED;TOPICAL018741-001Jul 27, 1983ABRXYesYes► Subscribe► Subscribe► Subscribe
Schering
DIPROLENE
betamethasone dipropionate
GEL, AUGMENTED;TOPICAL019408-002Nov 22, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck Sharp Dohme
DIPROLENE
betamethasone dipropionate
LOTION, AUGMENTED;TOPICAL019716-001Aug 1, 1988ABRXYesYes► Subscribe► Subscribe► Subscribe
Merck Sharp Dohme
DIPROLENE AF
betamethasone dipropionate
CREAM, AUGMENTED;TOPICAL019555-001Apr 27, 1987ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DIPROLENE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering
DIPROLENE
betamethasone dipropionate
CREAM, AUGMENTED;TOPICAL019408-001Jan 31, 1986► Subscribe► Subscribe
Merck Sharp Dohme
DIPROLENE
betamethasone dipropionate
OINTMENT, AUGMENTED;TOPICAL018741-001Jul 27, 1983► Subscribe► Subscribe
Schering
DIPROLENE
betamethasone dipropionate
GEL, AUGMENTED;TOPICAL019408-002Nov 22, 1991► Subscribe► Subscribe
Schering
DIPROLENE
betamethasone dipropionate
CREAM, AUGMENTED;TOPICAL019408-001Jan 31, 1986► Subscribe► Subscribe
Merck Sharp Dohme
DIPROLENE
betamethasone dipropionate
LOTION, AUGMENTED;TOPICAL019716-001Aug 1, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Chubb
Fuji
Healthtrust
AstraZeneca
Express Scripts
McKinsey
Chinese Patent Office
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot